The Atlanta Lung Cancer Symposium (ALCS) is a pioneering educational program addressing current, practical strategies and state-of-the-art approaches for managing lung cancer, and offering updates on the latest clinical data.
This one-day meeting will address the latest strategies and state-of-the-art approaches for managing lung cancer. Now in its fourteenth year, ALCS is a pioneering educational program that incorporates a multidisciplinary approach to presenting the most current literature and research related to lung cancer patient care.
To provide optimal care for patients with lung cancer, clinicians must continually evaluate novel treatment options and implement best practices regarding diagnosis and treatment. The latest clinical trial data and practice guidelines need to be routinely assessed and reviewed in order to be current and most impactful to the patient. Practitioners attending ALCS will emerge from the program updated on recent data and armed with new tools to help them improve clinical outcomes.
Suresh Ramalingam, MD, Taofeek Owonikoko, MD, PhD, and Kristin Higgins, MD of Winship Cancer Institute are the symposium co-chairs.
Registration is open to healthcare professionals.